International law firm Bird & Bird hires IP and regulatory expert Mette-Marie Buch Henrichsen as a new partner in its Life Sciences & Healthcare team.
Mette-Marie is a regulatory and compliance specialist advising Danish and EU clients across the full life science lifecycle on matters relating to medicinal products, medical devices, cosmetics, and food and dietary supplements. Her experience covers issues relating to clinical trials, sale and marketing, prices, reimbursement, substitution and the relationship between healthcare professionals and pharma & medico companies. Mette-Marie also has significant experience with issues relating to off-label recommendations, parallel import of medicinal products and medical devices, as well as with advising clients on various digital health and AI projects.
She also advises on the enforcement of patents, trademark rights and copyright as well as general marketing law, including injunction and preservation of evidence cases.
Her deep understanding of the life sciences sector enables her practice to span advisory work, contracts, high-stake disputes, and M&A support in complex transactions.
Co-heads of Bird & Bird’s Denmark office Casper Moltke-Leth and Peter Dann Jørgensen, commented: “We’re delighted to welcome Mette‑Marie to our Denmark team. Her life sciences regulatory expertise and strong network, coupled with her collaborative way of working, fit perfectly with the strengths of our existing team and collegiate culture. Her arrival will help build a market‑leading practice in Denmark while further strengthening our IP focus.”
Bird & Bird’s international Life Sciences & Healthcare Group co-heads Marc Martens and Mark Hilton said: “Denmark’s life sciences sector is a cornerstone of the economy and is one of its strongest global industries. Clients increasingly need joined‑up advice across regulatory, data privacy, digital health and AI; with Mette‑Marie’s Danish and EU expertise and Bird & Bird’s international network, we can provide consistent advice across borders. This cross‑border capability truly sets us apart and aligns with our strategic focus on life sciences internationally.”
Mette-Marie adds: “Denmark's life sciences companies are global in scope, and their regulatory, compliance and IP challenges extend well beyond Danish borders. That’s why Bird & Bird’s international platform provides the ideal environment for me to support clients with their regulatory and compliance needs. I’m excited to work with my colleagues internationally, driving growth in Denmark and across our wider network.”
